NCT01195454 - Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus® | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

December 31, 2010

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Insulin glargine (HOE901)

"Pharmaceutical form: Lantus solution for injection~Route of administration: subcutaneous"

DRUG

Insulin glargine (HOE901)

"Pharmaceutical form: New insulin glargine formulation solution for injection~Route of administration: subcutaneous"

Trial Locations (1)

Sanofi-Aventis Administrative Office, Berlin